Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue        
Revenue
Other revenue 45 1,030
Total revenue 45 1,030
Operating expenses:        
Research and development, net of reimbursements 11,622 6,771 30,552 15,802
General and administrative 2,729 3,073 11,025 8,041
Total operating expenses 14,351 9,844 41,577 23,843
Loss from operations (14,351) (9,799) (41,577) (22,813)
Other income:        
Interest income - net 1,075 325 2,083 443
Total other income 1,075 325 2,083 443
Net loss $ (13,276) $ (9,474) $ (39,494) $ (22,370)
Net loss per common share – basic (in Dollars per share) $ (0.49) $ (0.38) $ (1.5) $ (0.94)
Weighted average common shares outstanding – basic (in Shares) 27,058,397 25,164,599 26,329,298 23,691,218